Latest Breaking News On - Achilles therapeutics - Page 4 : comparemela.com

Achilles Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023

Achilles Therapeutics plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 69.67 million compared to USD 71.18 million a.

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings - Allurion Technologies (NYSE:ALUR), Achilles Therapeutics (NASDAQ:ACHL)

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P 500 also rose, gaining, 0.75% to 5,250.72.

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

Syncona notes investee Achilles's annual loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million.

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results - Allurion Technologies (NYSE:ALUR), Achilles Therapeutics (NASDAQ:ACHL)

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03.